- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Specialises in
- Haemato-oncology
Offers
- Face-to-face consultations
- Home chemotherapy
About me
Mike Dennis is a Clinical Haematologist who is an established expert in myeloid disease.
His expertise is in the management of acute myeloid leukaemia (AML), myelodysplasia (MDS), chronic myeloid leukaemia (CML), other associated myeloproliferative disorders (Myelofibrosis, CMML, ET, PRV) and bone marrow failure syndromes (including aplastic anaemia). This includes diagnosis and therapy (including stem cell transplantation)
His research focus is about getting access for patients to the most effective emerging agents. This is through clinical trial development of optimal therapy in AML of traditional and emerging agents, from site development and delivery of phase 1 studies to international trial governance and oversight.
He was appointed as a Consultant Haematologist at The Christie, Manchester in 2004. He qualified in Medicine from the University of Dundee, completed his physicians training in Liverpool before undertaking his first Haematology post in Australia. He then completed his Haematology training, including a MD, from the University of Liverpool.
In 2024 he was awarded a Manchester Academic Health Science Centre Clinical Chair by The University of Manchester's Faculty of Biology, Medicine and Health Promotions Committee for a major contribution to Haematology research.
Areas of interest
Leukaemias (AML and CML)
Myelodysplastic syndrome (MDS)
Myeloproliferative disorders (Myelofibrosis, ET, PRV, CMML)
Aplastic aneamia
Bone marrow transplantation
Medical secretaries
- Giselle Farr
- 0161 918 7162
- giselle.farr@nhs.net
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
The Christie Clinic (5-50)